Wednesday, August 20, 2025 8/20/2025

Callen-Lorde Transcend Program to Provide Status Neutral Services for Black, Hispanic and Multi-racial Transgender and Gender Diverse New Yorkers

Award Number: NU62PS924783
ORGANIZATION: NATIONAL CENTER FOR PREVENTION SERVICES
OPDIV: CDC
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: HEALTH SERVICES
PERIOD OF PERFORMANCE START DATE: 06/30/2022
PERIOD OF PERFORMANCE END DATE: 06/29/2026

Group Awards By:

View Award Description

Callen-Lorde Transcend Program to Provide Status Neutral Services for Black, Hispanic and Multi-racial Transgender and Gender Diverse New Yorkers - Callen-Lorde is a federally qualified health center with a mission to provide comprehensive health care and related services for New York City’s lesbian, gay, bisexual, transgender and queer (LGBTQ) communities, regardless of ability to pay. Callen-Lorde proposes to implement the Callen-Lorde Transcend Program in response to the Centers for Disease Control RFA PS22-2209, Transgender Status-Neutral Community-to-Clinic Models to End the HIV Epidemic within 3 sites located in the jurisdictions of New York, Bronx and Kings County in New York City, which are included in Phase 1 of the Ending the HIV Epidemic in the U.S. (EHE) initiative. The purpose of Callen-Lorde’s proposed Transcend Program is to address longstanding disparities in HIV prevention and treatment outcomes for Black, multi-racial and Hispanic transgender women in New York City. With the Transcend Program, Callen-Lorde will integrate biomedical HIV prevention and treatment interventions within gender-affirming medical care and supportive services for a target population of transgender and gender diverse (TGD) individuals, particularly Black and Latinx/Hispanic transgender women (TW). Callen-Lorde aims to improve access to HIV prevention and gender affirming care through targeted case-finding and outreach with collaborating CBOs, risk assessment and stratification and enhanced linkage services provided by dedicated care coordination and navigation staff. Under this initiative, Callen-Lorde will also enhance existing programming by providing access to long-acting injectable (LAI) PrEP, providing integrated injection coordination at each of our sites across New York City. The Transcend Injection Coordinators will provide LAI PrEP, ART and other indicated injection needs, including COVID vaccination. To support Transcend Program efforts, Callen-Lorde will also provide healthcare worker training and develop patient education materials. Callen-Lorde anticipates that a minimum of 250 Transcend Program patients will engage in services during Year 1 within Callen-Lorde Bronx, Brooklyn and Manhattan locations.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $500,000 )
2025	2025	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	4	8/18/2025	NON-COMPETING CONTINUATION	$500,000
2025	2024	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	01	3	1/31/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2024	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	02	3	2/11/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2024	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	4	8/18/2025	NON-COMPETING CONTINUATION	$0
2025	2023	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	01	3	1/31/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2023	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	4	8/18/2025	NON-COMPETING CONTINUATION	$0
2025	2023	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	02	3	2/11/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2022	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	01	3	1/31/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2022	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	02	3	2/11/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2022	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	4	8/18/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $500,000

Issue Date FY: 2024 ( Subtotal = $500,000 )
2024	2024	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	3	5/7/2024	NON-COMPETING CONTINUATION	$500,000
2024	2023	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	3	5/7/2024	NON-COMPETING CONTINUATION	$0
2024	2022	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	3	5/7/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $500,000

Issue Date FY: 2023 ( Subtotal = $500,000 )
2023	2023	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	01	2	9/26/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2023	COMMUNITY HEALTH PROJECT, INC.	356 W 18th St	New York	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	2	5/2/2023	NON-COMPETING CONTINUATION	$500,000
2023	2023	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	02	2	9/28/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2022	Community Health Project, Inc.	356 W 18th St	New York	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	03	1	1/26/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2022	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	01	2	9/26/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2022	Community Health Project, Inc.	356 W 18th St	New York	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	04	1	5/24/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2022	COMMUNITY HEALTH PROJECT, INC.	356 W 18TH ST	NEW YORK	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	02	2	9/28/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2022	COMMUNITY HEALTH PROJECT, INC.	356 W 18th St	New York	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	2	5/2/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $500,000

Issue Date FY: 2022 ( Subtotal = $581,155 )
2022	2022	Community Health Project, Inc.	356 W 18th St	New York	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	01	1	7/6/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2022	2022	Community Health Project, Inc.	356 W 18th St	New York	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	00	1	5/26/2022	NEW	$581,155
2022	2022	COMMUNITY HEALTH PROJECT, INC.	356 W 18th St	New York	NY	10011	NEW YORK	USA	Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Virus Syndrome (AIDS) Surveillance	02	1	9/13/2022	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
														Subtotal = $581,155

Grand Total All Awards = $2,081,155

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Callen-Lorde Transcend Program to Provide Status Neutral Services for Black, Hispanic and Multi-racial Transgender and Gender Diverse New Yorkers

Award Number: NU62PS924783

ORGANIZATION: NATIONAL CENTER FOR PREVENTION SERVICES

OPDIV: CDC

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: HEALTH SERVICES

PERIOD OF PERFORMANCE START DATE: 06/30/2022

PERIOD OF PERFORMANCE END DATE: 06/29/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer